Pei-Jing Hsu

Title: Pei-Jing Hsu: Innovator in Oral Drug Delivery Systems

Introduction

Pei-Jing Hsu is a notable inventor based in Meishan, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the area of drug delivery systems. Her innovative work focuses on improving the oral administration of drugs that are typically unstable or poorly absorbed.

Latest Patents

Pei-Jing Hsu holds a patent for the "Oral administration of unstable or poorly-absorbed drugs." This patent describes dosage forms and combinations that facilitate effective oral administration of drugs unsuitable for this route due to degradation caused by acid and digestive enzymes. The invention includes a self-microemulsifying drug delivery system (SMEDDS) combined with an antacid. This formulation can prevent drug degradation in the gastric environment and enhance the absorption of water-soluble drugs in the gastrointestinal tract. Notably, this system can be used to administer insulin orally, in a form that can be stored for extended periods and reconstituted before use.

Career Highlights

Pei-Jing Hsu is associated with Innopharmax, Inc., where she continues to advance her research in drug delivery technologies. Her work has the potential to revolutionize how certain medications are administered, making them more accessible and effective for patients.

Collaborations

Pei-Jing has collaborated with notable colleagues, including Yu-Tsai Yang and Jong-Jing Wang, who contribute to her research endeavors.

Conclusion

Pei-Jing Hsu's innovative approach to oral drug delivery systems exemplifies her commitment to enhancing pharmaceutical applications. Her contributions are paving the way for more effective treatment options for patients worldwide.